BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION (BARI)

BARI是一项冠状动脉成形术与搭桥手术的随机试验 患有多支冠状动脉疾病的患者需要 血运重建。这项研究随机选择了1,829名患者。在……里面 经过五年的随访，研究表明，5年的存活率没有 搭桥手术和搭桥手术在统计学上有显著差异 血管成形术，但血管成形术分配的患者需要大量 更多的手术(重复插管、血管成形术和搭桥 手术)进行5年随访。患者的亚群 在研究开始时用药治疗糖尿病有 最初被分配到血管成形术的存活率明显低于 搭桥手术(35%比19%，p=0.002)。在没有糖尿病的患者中 在进入时需要治疗，血管成形术和 手术分配的患者(9%比9%)。BARI的长期随访 病人是完整的。

BARI is a randomized trial of coronary angioplasty vs bypass surgery for patients with multivessel coronary artery disease requiring revascularization. The study randomized a total of 1,829 patients. In the five-year follow-up, the study showed that 5 year survival was not statistically significantly different between bypass surgery and angioplasty, but angioplasty assigned patients required significantly more procedures (repeat catheterization, angioplasty, and bypass surgery) during the 5-year follow-up. The subset of patients with diabetes mellitus treated with medications at study entry had significantly worse survival when initially assigned to angioplasty than bypass surgery (35% vs 19%, p=.002). Among patients without diabetes requiring treatment at entry, survival was identical in angioplasty and surgical-assigned patients (9% vs 9%). Extended follow-up of the BARI patients is complete.